Literature DB >> 618627

Effect of dopamine on hemodynamics and myocardial metabolism in shock following acute myocardial infarction in man.

H S Mueller, R Evans, S M Ayres.   

Abstract

Eight patients in shock associated with acute myocardial infarctions were treated with dopamine. We titrated the dopamine dose to increase mean arterial pressure to 65-70 mm Hg and urine output to greater than 40 ml/hr. Increase of heart rate to 120-125 beats/min and occurrence of potentially dangerous arrhythmias were limiting end-points. Dopamine administration averaged 17.2 microgram/kg/min. Heart rate increased from 95 to 118 beats/min (P less than 0.001), and mean arterial pressure rose from 60 to 65 mm Hg (P less than 0.05). Dopamine increased myocardial contractility as indicated by increase in cardiac index and systolic ejection rate, with only moderate decrease in systemic vascular resistance. Pulmonary wedge pressure and right atrial pressure decreased from 23 to 18 mm Hg (P less than 0.05) and from 10 to 8 mm Hg (P less than 0.001) respectively. Improvement in hemodynamic status by dopamine was associated with deterioration of myocardial metabolism. Myocardial oxygen extraction ratios and arterial-coronary sinus oxygen differences increased from 73 to 76% (P less than 0.05) and from 13.02 to 14.19 ml/100 ml (P less than 0.02) respectively. Myocardial lactate production increased from -8 to -15% (P = 0.05). We conclude that dopamine improved cardiac performance at the expense of myocardial oxygenation and that dopamine is potentially harmful to acutely ischemic myocardium.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 618627     DOI: 10.1161/01.cir.57.2.361

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

Review 1.  Cardiogenic shock.

Authors:  C E Handler
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

Review 2.  Inotropic agents in the treatment of cardiogenic shock.

Authors:  H S Mueller
Journal:  World J Surg       Date:  1985-02       Impact factor: 3.352

Review 3.  Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies.

Authors:  P Pentel; N Benowitz
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

4.  Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.

Authors:  J R Dawson; D S Thompson; M Signy; S M Juul; P Turnbull; B S Jenkins; M M Webb-Peploe
Journal:  Br Heart J       Date:  1985-09

5.  Cardiovascular response to dopamine in hypotensive preterm neonates with severe hyaline membrane disease.

Authors:  I Seri; T Tulassay; J Kiszel; T Machay; S Csömör
Journal:  Eur J Pediatr       Date:  1984-04       Impact factor: 3.183

Review 6.  Catecholamines in critical care. The commonly used catecholamines: receptor and clinical profile, indications and dosages.

Authors:  F W Santman
Journal:  Pharm Weekbl Sci       Date:  1992-10-16

7.  Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.

Authors:  J Bayliss; M Norell; R Canepa-Anson; S R Reuben; P A Poole-Wilson; G C Sutton
Journal:  Br Heart J       Date:  1983-03

8.  Effect of combined dopamine and bunazosin on the ischemic heart after occlusion of the coronary artery.

Authors:  T Katoh; F Mori; M Miyamoto; K Esato
Journal:  Jpn J Surg       Date:  1990-07

9.  A comparison of dopamine, dobutamine and isoproterenol in the treatment of shock.

Authors:  L I Worthley; P Tyler; J L Moran
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

10.  Comparison of haemodynamic responses to dopamine and salbutamol in severe cardiogenic shock complicating acute myocardial infarction.

Authors:  A D Timmis; M B Fowler; D A Chamberlain
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.